Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2008
10/23/2008US20080262221 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262102 Biodegradable polymer scaffolds for skeletal reconstruction; hydrogels with controllable hydrophilicity, swelling, mechanical properties; biocompatible, bioresorbable, injectable, and in-situ hardening; tissue engineering and controlled drug release; photocrosslinking; surgerical handling/positioning
10/23/2008US20080262072 Compositions And Kits Comprising A Melatonin Component And A Flavanol Component
10/23/2008US20080262068 Method of Tonic Treatment With Oxyphenbutazone Derivatives
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262034 selectively kill tumor cells by altering cancer cell metabolism and signal transduction pathways linked to the Warburg Effect;
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262005 Uracil-Type Gonadotropin-Releasing Hormone Receptor Antagonists and Methods Related Thereto
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261942 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/23/2008US20080261914 Stabilization of vitamin b12
10/23/2008US20080261909 Gene Delivery to Organs
10/23/2008US20080261905 Hexoses selected from tetrahydropyran; Preferred are hexitol, altritol, substituted altritols; novel modified nucleosides and nucleotides in single or double stranded oligonucleotides for RNA interference, antisense therapy; inhibit or decrease the expression of P-glycoprotein efflux pumps; cancer
10/23/2008US20080261891 Compositions and methods for using syringopeptin 25a and rhamnolipids
10/23/2008US20080261888 Platelet-derived growth factor-D (PDGF-D); stimulating cell proliferation, angiogensis
10/23/2008US20080261882 Methods for Inhibiting Heregulin and Treating Cancer
10/23/2008US20080261880 Synthetic approach to designed chemical structures
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/23/2008US20080261861 2-Micron Family Plasmid and Use Thereof
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080260876 Garlic Extract Compositions, Uses And Preparations Thereof
10/23/2008US20080260850 Delivery System For Bioactive Agents on the Basis of a Polymeric Drug Carrier Comprising an Amphiphilic Block Polymer and a Polylacticacid Derivative
10/23/2008US20080260845 Multiple active drug resin conjugate
10/23/2008US20080260835 Bioavailability; solid dispersion; dosage forms
10/23/2008US20080260824 Bioadhesive Rate-Controlled Oral Dosage Formulations
10/23/2008US20080260811 patches has pressure-sensitive adhesive matrix containing a polyisobutylene, free of permeation enhancer, for drug deliverying sufentanil through the skin to provide an analgesic effect, pain management; sustained release, side effect reduction; consistent concentration in blood
10/23/2008US20080260801 Composite material, especially for medical use, and method for producing the material
10/23/2008US20080260800 Potentiation with such as small intestinal submucosal (SIS) tissue; harnessing inflammatory provoking activity; prostate glands
10/23/2008US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules
10/23/2008US20080260752 Prevention and reduction of blood loss
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260743 Means and Methods for Detecting Methylated Dna
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260740 Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer
10/23/2008US20080260738 Single chain fc, methods of making and methods of treatment
10/23/2008US20080260732 Integrin specific immunoglobulin for inhibiting vascularization and treating cell proliferative disorders
10/23/2008US20080260724 Using pattern recognition receptor specific immunoglobulin to target and treat fungal infection
10/23/2008US20080260722 Nutrient broth comprising neurotrophins for use in propgation of nervous system tissues; tissue engineering and repair; regenerative medicine
10/23/2008US20080260707 Isolated homozygous stem cells, differentiated cells derived therefrom and materials and methods for making and using same
10/23/2008US20080260706 Transient Transfection with RNA
10/23/2008US20080260694 Progenitor cell culture for use tissue engineering, tissue repair and regenerative medicine
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008US20080260669 Aromachemicals
10/23/2008US20080260648 Pharmaceutical Preparation Containing Magnetic Vesicular Particles, Manufacturing Method Thereof and Diagnostic Therapeutic System
10/23/2008US20080260646 Imaging Reporters of Transgene Expression
10/23/2008US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682855A1 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982986A1 Pyrrolopyridazinone compound
10/22/2008EP1982984A2 Tricyclic thrombin receptor antagonists
10/22/2008EP1982981A1 Process for production of lasofoxifene or analogue thereof
10/22/2008EP1982718A1 Anti-cancer pharmaceutical composition
10/22/2008EP1982708A1 Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease
10/22/2008EP1982707A1 Use of hydroxytyrosol as anti-aging agent
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1982602A1 Feed additive for treating animal teeth
10/22/2008EP1981493A1 Acat inhibitors and their use in the prevention or treatment of fibrosis
10/22/2008EP1654226B1 (2s,4s)-4-fluoro-1- 4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl -2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008EP1443945B1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia
10/22/2008EP1425018B1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1326631B2 Botulinumtoxin for treating endocrine disorders
10/22/2008EP0746612B1 Synthetic polynucleotides
10/22/2008CN101291668A Atr inhibitor
10/22/2008CN101291661A 2-aminoalcohols for the treatment of neurodegenerative diseases
10/22/2008CN101289450A Tyrosine phthalocyanines derivates, preparation thereof and applications in preparation of photodynamic drugs
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101288746A Yuqitaiduqing for treating fetal toxication of newborn infant and its preparation method
10/22/2008CN100427609C Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
10/22/2008CN100427504C TNF alpha high-affinity chimeric antibody and use thereof
10/22/2008CN100427141C Composition of SOD and animal medicine or its extractives, and its prepn. method
10/22/2008CN100427133C Externally applied medicine for cutting therapy
10/22/2008CN100427105C Cell-repairing oral liquid
10/22/2008CN100427103C Activity combination of marine life and application
10/22/2008CN100427096C Method for preparing suspension of rhodiola root nanoliposome
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/22/2008CN100427092C Agent for derivating metamorphosis of sea cyphonaute larva based on information transfer, and its application
10/22/2008CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/22/2008CN100427077C Dry powder inhalation system for transpulmonary administration
10/21/2008US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439383 Sodium channel blockers
10/21/2008US7439359 Antiproliferative agents; antitumor agents; binding to chaperone protein
10/21/2008US7439342 Thrombopoietin mimetics
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 1564